Finance

Lists
ELTP:OTCMKTS
Elite Pharmaceuticals, Inc. Common Stock
0,23 US$
+0,73%
(+0,0017) 1D
2 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELTP...
Open
0,23 US$
High
0,24 US$
Low
0,22 US$
Mkt. cap
243,07 მლნ.
Avg. vol.
818,80 ათ.
Volume
1,87 მლნ.
P/E ratio
4,66
52-wk high
0,69 US$
52-wk low
0,22 US$
EPS
0,05 US$
Beta
0,33
Shares outstanding
1,08 მლრდ.
No. of employees
65
Open
0,23 US$
High
0,24 US$
Low
0,22 US$
Mkt. cap
243,07 მლნ.
Avg. vol.
818,80 ათ.
Volume
1,87 მლნ.
P/E ratio
4,66
52-wk high
0,69 US$
52-wk low
0,22 US$
EPS
0,05 US$
Beta
0,33
Shares outstanding
1,08 მლრდ.
No. of employees
65
News stories
From web sources and news partners
marketscreener.com
marketscreener.com
·
34 წუთის წინ
Vertical Aerospace Receives NYSE Noncompliance Notice
Business Wire
Business Wire
·
24 წუთის წინ
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
GlobeNewswire
·
1 საათის წინ
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance
Yahoo Finance
·
30 წუთის წინ
Alarm.com (NASDAQ:ALRM) Q2 Earnings: Leading The Vertical Software Pack
About Elite Pharmaceuticals, Inc. Common Stock
CEO-
Employees65
Founded1997
HeadquartersNorthvale, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Websiteelitepharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
36,32 მლნ.
31,59 მლნ.
40,75 მლნ.
32,36 მლნ.
Cost of goods sold
22,25 მლნ.
18,64 მლნ.
19,98 მლნ.
18,85 მლნ.
Cost of revenue
22,25 მლნ.
18,64 მლნ.
19,98 მლნ.
18,85 მლნ.
Research and development expenses
1,39 მლნ.
1,04 მლნ.
1,64 მლნ.
2,03 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,03 მლნ.
2,47 მლნ.
7,70 მლნ.
3,55 მლნ.
Operating expense
5,86 მლნ.
3,94 მლნ.
9,74 მლნ.
5,98 მლნ.
Total operating expenses
28,11 მლნ.
22,58 მლნ.
29,71 მლნ.
24,83 მლნ.
Operating income
8,21 მლნ.
9,01 მლნ.
11,03 მლნ.
7,53 მლნ.
Other non operating income
7,55 მლნ.
11,82 მლნ.
10,63 მლნ.
94,25 ათ.
EBT including unusual items
15,69 მლნ.
20,83 მლნ.
20,85 მლნ.
7,72 მლნ.
EBT excluding unusual items
15,69 მლნ.
20,83 მლნ.
21,70 მლნ.
7,72 მლნ.
Income tax expense
1,99 მლნ.
2,24 მლნ.
2,39 მლნ.
1,81 მლნ.
Effective tax rate
12,67%
10,75%
11,48%
23,40%
Other operating expenses
-
-
-
-
Net income
13,70 მლნ.
18,59 მლნ.
18,46 მლნ.
5,91 მლნ.
Net profit margin
37,73%
58,86%
45,31%
18,27%
Earnings per share
-
-
-
-
Interest and investment income
4,92 ათ.
83,60 ათ.
114,79 ათ.
166,12 ათ.
Interest expense
-82,47 ათ.
-80,20 ათ.
-75,06 ათ.
-73,10 ათ.
Net interest expenses
-77,55 ათ.
3,40 ათ.
39,73 ათ.
93,01 ათ.
Depreciation and amortization charges
394,86 ათ.
388,14 ათ.
369,99 ათ.
367,76 ათ.
EBITDA
8,61 მლნ.
9,40 მლნ.
11,40 მლნ.
7,90 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები